
|Videos|July 27, 2021
Dr. Helfand on the increasing role of genomic testing in prostate cancer
Author(s)Urology Times staff
Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, explains the increased significance of genomic testing in the field of prostate cancer.
Advertisement
Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, explains the increased significance of genomic testing in the field of prostate cancer.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Novel tool may help predict early PSA response to ARPIs in mHSPC
2
67Cu-SAR-bisPSMA continues to show promise in mCRPC
3
Assessing fit in urology residency through asynchronous video
4
RCMIGI trial supports feasibility of reduced margins in image-guided prostate radiotherapy
5




















